LABORATORIOS FARMACEUTICOS ROVI, S.A. «12345...» Page 2 out of 24 from 01/07/1988 to 20/03/2018 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 25/10/2017 08:19 LABORATORIOS FARMACEUTICOS ROVI, S.A. Others on business performance and financial information The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® Project in spanish Register number: 257753 24/10/2017 08:05 LABORATORIOS FARMACEUTICOS ROVI, S.A. Others on business performance and financial information The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® project. Register number: 257683 05/10/2017 09:39 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity contracts and specialists Liquidity contract: transactions conducted from 11 July to 30 September 2017 Register number: 257047 Corrected by 256992 of 03/10/2017 (13:53) 03/10/2017 13:53 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity contracts and specialists Liquidity contract: transactions conducted from 11 July to 30 September 2017 Register number: 256992 Corrected by 257047 of 05/10/2017 (09:39) 07/09/2017 17:45 LABORATORIOS FARMACEUTICOS ROVI, S.A. Others on business performance and financial information The Company informs that commences the enoxaparin biosimilar marketing in Germany Register number: 256121 26/07/2017 07:52 LABORATORIOS FARMACEUTICOS ROVI, S.A. Information on P&L The Company releases the presentation related to the First Half of 2017 financial results Register number: 254996 26/07/2017 07:46 LABORATORIOS FARMACEUTICOS ROVI, S.A. Information on P&L The Company releases the press release related to the First Half 2017 financial results Register number: 254993 26/07/2017 07:38 LABORATORIOS FARMACEUTICOS ROVI, S.A. Interim financial information La sociedad remite información sobre los resultados del primer semestre de 2017 Register number: 254990 25/07/2017 18:06 LABORATORIOS FARMACEUTICOS ROVI, S.A. Others about corporate governance La Sociedad informa sobre la modificación de su Reglamento Interno de Conducta en los Mercados de Valores. Register number: 254952 10/07/2017 19:20 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity contracts and specialists The Company informs that has subscribed a new liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. Register number: 254434 Related with 270230 of 04/10/2018 (23:13) Page 2 out of 24 «12345...»